Oxytocin in schizophrenia: a review of evidence for its therapeutic effects
Authors:
- 24 June 2012
- journal article
- review article
- Published by Cambridge University Press (CUP) in Acta Neuropsychiatrica
- Vol. 24 (3) , 130-146
Abstract
Background:The suggestion that the neurohormone oxytocin may have clinical application in the treatment of schizophrenia was first published in 1972. Since then, a considerable body of research on a variety of fronts – including several recent double-blind treatment trials – has buttressed these early reports, providing support for the assertion that the oxytocin system is a promising and novel therapeutic target for this devastating malady. Herein, we review the diverse, convergent lines of evidence supporting the therapeutic potential of oxytocin in psychotic illness. Methods:We performed a systematic review of preclinical and clinical literature pertaining to oxytocin's role in schizophrenia. Results:Multiple lines of evidence converge to support the antipsychotic potential of oxytocin. These include several animal models of schizophrenia, pharmacological studies examining the impact of antipsychotics on the oxytocin system, human trials in patients examining the aspects of the oxytocin system and several double-blind, placebo-controlled clinical treatment trials. Conclusions:There exists considerable, convergent evidence that oxytocin has potential as a novel antipsychotic with a unique mechanism of action. Auspiciously, based on the few chronic trials to date, its safety profile and tolerability appear very good. That said, several critical clinical questions await investigation before widespread use is clinically warranted.Keywords
This publication has 202 references indexed in Scilit:
- The human amygdala is necessary for developing and expressing normal interpersonal trustNeuropsychologia, 2011
- Oxytocin receptor gene polymorphism (rs2254298) interacts with familial risk for psychopathology to predict symptoms of depression and anxiety in adolescent girlsPsychoneuroendocrinology, 2011
- The environment and susceptibility to schizophreniaProgress in Neurobiology, 2011
- Association Between the Oxytocin Receptor Gene and Amygdalar Volume in Healthy AdultsBiological Psychiatry, 2010
- Adjunctive Intranasal Oxytocin Reduces Symptoms in Schizophrenia PatientsBiological Psychiatry, 2010
- Effect of Antipsychotic Medication Alone vs Combined With Psychosocial Intervention on Outcomes of Early-Stage SchizophreniaArchives of General Psychiatry, 2010
- Promise and Pitfalls of Animal Models of SchizophreniaCurrent Psychiatry Reports, 2010
- The Challenge of Translation in Social Neuroscience: A Review of Oxytocin, Vasopressin, and Affiliative BehaviorNeuron, 2010
- A Hormone-Activated Central Pattern Generator for CourtshipCurrent Biology, 2010
- Prenatal stress generates deficits in rat social behavior: Reversal by oxytocinBrain Research, 2007